The FDA is said to be making a U-turn on uniQure’s one-time gene therapy candidate for Huntington’s disease despite the treatment being hailed as a game-changer. | FDA is said to be making a U-turn on ...
Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...
Shortly after taking reins at BioMarin, CEO Alexander Hardy laid out three paths the company could take for its struggling ...
Health Secretary Robert F. Kennedy Jr. called the treatment 'a powerful glimpse into the future of personalized medicine' ...
Mother Daphne Graskewicz-Prado of Southern Illinois told Newsweek: “I wasn’t going to accept the terminal diagnosis.” ...
Industry leaders say uncertainty in funding, clinical development and manufacturing is driving companies to embrace digital ...
I’LL ADMIT it, I’m drawn to anything that promises younger looking skin. And recently TikTok has been flooded with people ...
After Intellia Therapeutics paused a pair of phase 3 trials for its CRISPR therapy in response to a liver safety signal, the ...
Foldvary recommends several evidence-based habits for better sleep. Avoid eating or exercising right before bedtime, as both ...
Alkem Foundation partners with IIT Bombay to establish a ₹77 crore research center for immuno-therapeutics and regenerative medicines.
In a pop-up city off the coast of Honduras, longevity startups are trying to fast-track anti-aging drugs. Is this the future ...
The Chosun Ilbo on MSN
Samsung Backs U.S. Gene-Editing Firm Arbor Bio
Samsung is proceeding with an investment in U.S.-based Arbor Biotechnologies (Arbor Bio), a company specializing in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback